DB
NVO

Dmitry Balyasny’s Novo Nordisk NVO Stock Holding History

Dmitry Balyasny’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.13M Sell
190,500
-106,400
-36% -$4.57M 0.01% 1091
2026
Q1 		$10.9M Buy
296,900
+239,900
+421% +$11.4M 0.01% 997
2025
Q4 		$2.9M Sell
57,000
-299,600
-84% -$15.3M ﹤0.01% 1686
2025
Q3 		$19.8M Buy
356,600
+352,400
+8,390% +$20.6M 0.03% 723
2025
Q2 		$290K Sell
4,200
-113,600
-96% -$7.73M ﹤0.01% 2483
2025
Q1 		$8.18M Sell
117,800
-382,300
-76% -$31.6M 0.01% 1030
2024
Q4 		$43M Buy
+500,100
New +$54.1M 0.06% 369
2024
Q1 		– Sell
-300,000
Closed -$31M – 2958
2023
Q4 		$31M Buy
+300,000
New +$29.7M 0.06% 437
2023
Q3 		– Sell
-182,000
Closed -$14.7M – 2577
2023
Q2 		$14.7M Buy
+182,000
New +$14.9M 0.03% 634
2021
Q3 		– Sell
-260,000
Closed -$10.9M – 2280
2021
Q2 		$10.9M Buy
+260,000
New +$10.1M 0.05% 489
2020
Q1 		– Sell
-1,100,000
Closed -$31.8M – 1415
2019
Q4 		$31.8M Buy
1,100,000
+700,000
+175% +$19.4M 0.19% 159
2019
Q3 		$10.3M Buy
+400,000
New +$10.1M 0.07% 384
2019
Q1 		– Sell
-360,000
Closed -$8.29M – 1567
2018
Q4 		$8.29M Sell
360,000
-60,000
-14% -$1.33M 0.06% 392
2018
Q3 		$9.9M Sell
420,000
-370,000
-47% -$9.03M 0.04% 493
2018
Q2 		$18.2M Buy
+790,000
New +$18.8M 0.08% 335

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Dmitry Balyasny's NVO Position: Q2 2026 in Review

Dmitry Balyasny increased its Novo Nordisk (NVO) stake by 190% in Q2 2026, buying an estimated $31.2M and bringing the position to 1,109,982 shares worth $53.2M. The position accounts for 0.07% of the portfolio, ranked #341.

Dmitry Balyasny first reported a position in NVO in Q1 2018 and has held it in 22 quarters since. The position peaked at $106M in Q2 2025. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Dmitry Balyasny held 1,109,982 shares of Novo Nordisk worth $53.2M as of Q2 2026.
  • Dmitry Balyasny bought 726,836 Novo Nordisk shares in Q2 2026, an estimated $31.2M.
  • Novo Nordisk made up 0.07% of Dmitry Balyasny's portfolio in Q2 2026, its #341 holding.
  • Dmitry Balyasny first reported a position in Novo Nordisk in Q1 2018 and has held it in 22 quarters since.
  • Dmitry Balyasny's Novo Nordisk position peaked at $106M in Q2 2025.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.